Center for Advanced Molecular & Immunological Therapies

U of A Health Sciences Office of Communications

Vaccinated people generated an overall protective immune response to the Delta and Omicron strains of COVID-19, though with slightly fewer antibodies for the mutated parts of the virus.

A CAMI scientist is leading efforts to create a new kind of cancer immunotherapy – neoantigen-specific cancer vaccines – to target patient-specific tumors and destroy cancer cells.

The Maricopa County Board of Supervisors increased its financial support of CAMI to a total of $8 million with another $4 million distribution of ARPA funds.

Researchers at the U of A Health Sciences Center for Advanced Molecular and Immunological Therapies are investigating the potential of genetically engineered T cells to treat autoimmune diseases.

Dr. Hannah Pizzato, a scientist at the U of A Health Sciences Center for Advanced Molecular and Immunological Therapies, is working on a stem cell-based therapy for Type 1 diabetes.

U of A Health Sciences researchers are working to enhance prevention and treatment options for autoimmune diseases, which can be hard to diagnose and treat.

Dr. Deepta Bhattacharya is shepherding a new era in immunology research as the inaugural executive director of the U of A Health Sciences Center for Advanced Molecular and Immunological Therapies.

The total funding comprises ground lease rent abatement and Downtown Community Reinvestment Funds.